In the last 12 months, insiders at Lyell Immunopharma, Inc. ($LYEL) filed 136 transactions with the SEC: 7 open-market purchases totaling $25,447,900 and 26 sales totaling $618,555. Net insider sentiment: net buying.
Lyell Immunopharma, Inc. operates in the Pharmaceutical preparations industry (Life sciences sector).
Most Active Insiders
- ARCH Venture Partners IX, LLC (TenPercentOwner) — 1 transaction totaling $12,499,985
- ARCH Venture Fund XIII, L.P. (TenPercentOwner) — 1 transaction totaling $12,499,985
- Seely Lynn (President and CEO) — 17 transactions totaling $382,157
- Klausner Richard (Director) — 3 transactions totaling $132,286
- Newton Charles W. (Chief Financial Officer) — 19 transactions totaling $129,725
View all SEC Filings for Lyell Immunopharma, Inc. (LYEL).
Set Up your own filters →Recent Insider Transactions
| Transaction Date | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|
| March 9, 2026 | Shah Smital | Chief Fin. and Bus. Officer | A | Option (right to buy) | 140000 | $0.00 | 140,000.0000 | 21,218,217 | 9999.99% | 0.66% |
| March 6, 2026 | ARCH Venture Partners IX, LLC | TenPercentOwner | P | Common Stock | 488090 | $25.61 | 3,247,162.0000 | 21,218,217 | 17.69% | 2.30% |
| March 6, 2026 | ARCH Venture Fund XIII, L.P. | TenPercentOwner | P | Common Stock | 488090 | $25.61 | 3,247,162.0000 | 21,218,217 | 17.69% | 2.30% |
| Feb. 11, 2026 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 1671 | $23.39 | 16,938.0000 | 21,218,217 | 8.98% | 0.01% |
| Feb. 11, 2026 | Seely Lynn | President and CEO | S | Common Stock | 7455 | $23.39 | 74,266.0000 | 21,218,217 | 9.12% | 0.04% |
| Feb. 11, 2026 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 1236 | $23.39 | 17,795.0000 | 21,218,217 | 6.49% | 0.01% |
| Feb. 10, 2026 | Lee Gary K. | Chief Scientific Officer | A | Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 21,218,217 | 9999.99% | 0.24% |
| Feb. 10, 2026 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 109 | $23.12 | 19,031.0000 | 21,218,217 | 0.57% | 0.00% |
| Feb. 10, 2026 | Hill Stephen J. | Chief Operating Officer | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 21,218,217 | 9999.99% | 0.31% |
| Feb. 9, 2026 | Seely Lynn | President and CEO | A | Common Stock | 20000 | $0.00 | 82,159.0000 | 21,218,217 | 32.18% | 0.09% |
| Feb. 10, 2026 | Seely Lynn | President and CEO | S | Common Stock | 438 | $23.12 | 81,721.0000 | 21,218,217 | 0.53% | 0.00% |
| Feb. 10, 2026 | Seely Lynn | President and CEO | A | Option (right to buy) | 155000 | $0.00 | 155,000.0000 | 21,218,217 | 9999.99% | 0.73% |
| Feb. 10, 2026 | Meltz Mark A | General Counsel | A | Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 21,218,217 | 9999.99% | 0.24% |
| Feb. 10, 2026 | Bulis Veronica Sanchez | VP, Corporate Controller | A | Common Stock | 8750 | $0.00 | 15,891.0000 | 21,218,217 | 122.53% | 0.04% |
| Feb. 10, 2026 | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 254 | $23.12 | 15,637.0000 | 21,218,217 | 1.60% | 0.00% |
| Feb. 10, 2026 | Shook David | Chief Medical Officer | A | Option (right to buy) | 50000 | $0.00 | 50,000.0000 | 21,218,217 | 9999.99% | 0.24% |
| Feb. 10, 2026 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 147 | $23.12 | 18,609.0000 | 21,218,217 | 0.78% | 0.00% |
| Feb. 9, 2026 | Hill Stephen J. | Chief Operating Officer | A | Common Stock | 4000 | $0.00 | 19,140.0000 | 21,218,217 | 26.42% | 0.02% |
| Feb. 9, 2026 | Lee Gary K. | Chief Scientific Officer | A | Common Stock | 4000 | $0.00 | 18,756.0000 | 21,218,217 | 27.11% | 0.02% |
| Dec. 30, 2025 | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 936 | $32.32 | 7,141.0000 | 21,218,217 | 11.59% | 0.00% |
| Dec. 24, 2025 | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 1136 | $38.67 | 8,077.0000 | 21,218,217 | 12.33% | 0.01% |
| Nov. 10, 2025 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 138 | $16.16 | 15,366.0000 | 295,228,868 | 0.89% | 0.00% |
| Nov. 10, 2025 | Seely Lynn | President and CEO | S | Common Stock | 412 | $16.11 | 67,159.0000 | 295,228,868 | 0.61% | 0.00% |
| Nov. 10, 2025 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 95 | $16.12 | 15,750.0000 | 295,228,868 | 0.60% | 0.00% |
| Nov. 10, 2025 | Bulis Veronica Sanchez | VP, Corporate Controller | S | Common Stock | 239 | $16.10 | 9,213.0000 | 295,228,868 | 2.53% | 0.00% |
| Oct. 27, 2025 | Hill Stephen J. | Chief Operating Officer | A | Option (right to buy) | 75000 | $0.00 | 75,000.0000 | 295,228,868 | 9999.99% | 0.03% |
| Oct. 27, 2025 | Lee Gary K. | Chief Scientific Officer | A | Option (right to buy) | 68000 | $0.00 | 68,000.0000 | 295,228,868 | 9999.99% | 0.02% |
| Oct. 27, 2025 | Seely Lynn | President and CEO | A | Option (right to buy) | 175000 | $0.00 | 175,000.0000 | 295,228,868 | 9999.99% | 0.06% |
| Aug. 21, 2025 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 1453 | $10.54 | 15,504.0000 | 295,228,868 | 8.57% | 0.00% |
| Aug. 21, 2025 | Newton Charles W. | Chief Financial Officer | S | Common Stock | 1453 | $10.54 | 25,306.0000 | 295,228,868 | 5.43% | 0.00% |
| Aug. 20, 2025 | Lee Gary K. | Chief Scientific Officer | A | Common Stock | 8000 | $0.00 | 16,957.0000 | 295,228,868 | 89.32% | 0.00% |
| Aug. 20, 2025 | Seely Lynn | President and CEO | A | Common Stock | 40000 | $0.00 | 74,828.0000 | 295,228,868 | 114.85% | 0.01% |
| Aug. 20, 2025 | Hill Stephen J. | Chief Operating Officer | A | Common Stock | 8000 | $0.00 | 16,849.0000 | 295,228,868 | 90.41% | 0.00% |
| Aug. 21, 2025 | Seely Lynn | President and CEO | S | Common Stock | 7257 | $10.54 | 67,571.0000 | 295,228,868 | 9.70% | 0.00% |
| Aug. 21, 2025 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 1004 | $10.54 | 15,845.0000 | 295,228,868 | 5.96% | 0.00% |
| Aug. 20, 2025 | Newton Charles W. | Chief Financial Officer | A | Common Stock | 8000 | $0.00 | 26,759.0000 | 295,228,868 | 42.65% | 0.00% |
| Aug. 11, 2025 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 91 | $10.53 | 8,943.0000 | 295,228,868 | 1.01% | 0.00% |
| Aug. 11, 2025 | Seely Lynn | President and CEO | S | Common Stock | 391 | $10.53 | 35,234.0000 | 295,228,868 | 1.10% | 0.00% |
| Aug. 12, 2025 | Newton Charles W. | Chief Financial Officer | S | Common Stock | 136 | $10.34 | 18,759.0000 | 295,228,868 | 0.72% | 0.00% |
| Aug. 11, 2025 | Newton Charles W. | Chief Financial Officer | S | Common Stock | 131 | $10.53 | 18,895.0000 | 295,228,868 | 0.69% | 0.00% |
| Aug. 12, 2025 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 136 | $10.34 | 8,957.0000 | 295,228,868 | 1.50% | 0.00% |
| Aug. 11, 2025 | Lee Gary K. | Chief Scientific Officer | S | Common Stock | 131 | $10.53 | 9,093.0000 | 295,228,868 | 1.42% | 0.00% |
| Aug. 12, 2025 | Hill Stephen J. | Chief Operating Officer | S | Common Stock | 94 | $10.34 | 8,849.0000 | 295,228,868 | 1.05% | 0.00% |
| Aug. 12, 2025 | Seely Lynn | President and CEO | S | Common Stock | 406 | $10.34 | 34,828.0000 | 295,228,868 | 1.15% | 0.00% |
| June 9, 2025 | Shook David | Chief Medical Officer | A | Option (right to buy) | 43750 | $0.00 | 43,750.0000 | 295,228,868 | 9999.99% | 0.01% |
| June 9, 2025 | Bachleda Mark | Not found | A | Option (right to buy) | 13000 | $0.00 | 13,000.0000 | 295,228,868 | 9999.99% | 0.00% |
| June 9, 2025 | Meltz Mark A | General Counsel | A | Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 295,228,868 | 9999.99% | 0.03% |
| June 9, 2025 | Shook David | Chief Medical Officer | A | Common Stock | 21900 | $0.00 | 21,900.0000 | 295,228,868 | 9999.99% | 0.01% |
| May 15, 2025 | NABEL ELIZABETH G | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| May 15, 2025 | Klausner Richard | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| May 15, 2025 | RIEFLIN WILLIAM JL | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| May 15, 2025 | FRIEDMAN CATHY | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| May 15, 2025 | BRAWLEY OTIS W | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| May 15, 2025 | Ramachandra Sumant | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 295,228,868 | 9999.99% | 0.04% |
| March 31, 2025 | BRAWLEY OTIS W | Not found | P | Common Stock | 35640 | $0.56 | 35,640.0000 | 295,228,868 | 9999.99% | 0.01% |
| March 21, 2025 | Ramachandra Sumant | Not found | P | Common Stock | 200000 | $0.58 | 200,000.0000 | 295,228,868 | 9999.99% | 0.07% |
| March 14, 2025 | Seely Lynn | President and CEO | P | Common Stock | 175000 | $0.61 | 712,500.0000 | 295,228,868 | 32.56% | 0.06% |
| March 17, 2025 | Newton Charles W. | Chief Financial Officer | P | Common Stock | 200000 | $0.56 | 372,725.0000 | 295,228,868 | 115.79% | 0.07% |
| March 14, 2025 | Klausner Richard | Not found | P | Common Stock | 158000 | $0.60 | 3,811,199.0000 | 295,228,868 | 4.32% | 0.05% |
| Feb. 10, 2025 | Newton Charles W. | Chief Financial Officer | A | Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Lee Gary K. | Chief Scientific Officer | A | Common Stock | 112500 | $0.00 | 176,696.0000 | 0 | 175.24% | 0.00% |
| Feb. 10, 2025 | Lee Gary K. | Chief Scientific Officer | A | Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Lee Gary K. | Chief Scientific Officer | A | Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Hill Stephen J. | Chief Operating Officer | A | Common Stock | 112500 | $0.00 | 172,899.0000 | 0 | 186.26% | 0.00% |
| Feb. 10, 2025 | Hill Stephen J. | Chief Operating Officer | A | Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Hill Stephen J. | Chief Operating Officer | A | Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Newton Charles W. | Chief Financial Officer | A | Common Stock | 112500 | $0.00 | 172,725.0000 | 0 | 186.80% | 0.00% |
| Feb. 10, 2025 | Newton Charles W. | Chief Financial Officer | A | Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Lang Matthew | Chief Business Officer | A | Common Stock | 112500 | $0.00 | 162,500.0000 | 0 | 225.00% | 0.00% |
| Feb. 10, 2025 | Lang Matthew | Chief Business Officer | A | Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Lang Matthew | Chief Business Officer | A | Option (right to buy) | 56250 | $0.00 | 56,250.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Seely Lynn | President and CEO | A | Common Stock | 337500 | $0.00 | 537,500.0000 | 0 | 168.75% | 0.00% |
| Feb. 10, 2025 | Seely Lynn | President and CEO | A | Option (right to buy) | 1350000 | $0.00 | 1,350,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 10, 2025 | Seely Lynn | President and CEO | A | Option (right to buy) | 168750 | $0.00 | 168,750.0000 | 0 | 9999.99% | 0.00% |
| Oct. 31, 2024 | Ramachandra Sumant | Not found | A | Option (right to buy) | 260000 | $0.00 | 260,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | FRIEDMAN CATHY | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Bishop Hans Edgar | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | NELSEN ROBERT | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | Klausner Richard | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | RIEFLIN WILLIAM JL | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | BRAWLEY OTIS W | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| June 14, 2024 | NABEL ELIZABETH G | Not found | A | Option (right to buy) | 130000 | $0.00 | 130,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Newton Charles W. | Chief Financial Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Seely Lynn | President and CEO | A | Common Stock | 200000 | $0.00 | 200,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Newton Charles W. | Chief Financial Officer | A | Common Stock | 40000 | $0.00 | 48,729.0000 | 0 | 458.24% | 0.00% |
| Feb. 9, 2024 | Lee Gary K. | Chief Scientific Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Lee Gary K. | Chief Scientific Officer | A | Common Stock | 40000 | $0.00 | 52,700.0000 | 0 | 314.96% | 0.00% |
| Feb. 9, 2024 | Hill Stephen J. | Chief Operating Officer | A | Stock Option (right to buy) | 400000 | $0.00 | 400,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Hill Stephen J. | Chief Operating Officer | A | Common Stock | 40000 | $0.00 | 48,928.0000 | 0 | 448.03% | 0.00% |
| Feb. 9, 2024 | Lang Matthew | Chief Business Officer | A | Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 9, 2024 | Lang Matthew | Chief Business Officer | A | Common Stock | 50000 | $0.00 | 50,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 100000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 100000 | $0.00 | 100,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 450000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 450000 | $0.00 | 450,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 165000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 165000 | $0.00 | 165,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 85000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | D | Stock Option (right to buy) | 700000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | A | Stock Option (right to buy) | 3612000 | $0.00 | 3,612,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | D | Stock Option (right to buy) | 3612000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | A | Stock Option (right to buy) | 190000 | $0.00 | 190,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | D | Stock Option (right to buy) | 190000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | A | Stock Option (right to buy) | 516000 | $0.00 | 516,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | D | Stock Option (right to buy) | 516000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Newton Charles W. | Chief Financial Officer | D | Stock Option (right to buy) | 500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Lee Gary K. | Chief Scientific Officer | A | Stock Option (right to buy) | 800000 | $0.00 | 800,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Lee Gary K. | Chief Scientific Officer | D | Stock Option (right to buy) | 800000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Seely Lynn | President and CEO | A | Stock Option (right to buy) | 7500000 | $0.00 | 7,500,000.0000 | 0 | 9999.99% | 0.00% |
| Nov. 16, 2023 | Seely Lynn | President and CEO | D | Stock Option (right to buy) | 7500000 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Nov. 16, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Stock Option (right to buy) | 500000 | $0.00 | 500,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Bishop Hans Edgar | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | Klausner Richard | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | RIEFLIN WILLIAM JL | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | FRIEDMAN CATHY | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | NELSEN ROBERT | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | NABEL ELIZABETH G | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Sept. 8, 2023 | BRAWLEY OTIS W | Director | A | Option (right to buy) | 55000 | $0.00 | 55,000.0000 | 0 | 9999.99% | 0.00% |
| Aug. 15, 2023 | Klausner Richard | Director | S | Common Stock | 58020 | $2.28 | 3,898,714.0000 | 0 | 1.47% | 0.00% |
| Aug. 10, 2023 | Lang Matthew | Chief Business Officer | A | Option (right to buy) | 2250000 | $0.00 | 2,250,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | FRIEDMAN CATHY | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | BRAWLEY OTIS W | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Klausner Richard | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | NABEL ELIZABETH G | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | NELSEN ROBERT | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | RIEFLIN WILLIAM JL | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| June 16, 2023 | Bishop Hans Edgar | Director | A | Option (right to buy) | 65000 | $0.00 | 65,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Albertson Tina M. | Chief Medical Officer | A | Option (right to buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Hill Stephen J. | Chief Technical Ops. Officer | A | Option (right to buy) | 900000 | $0.00 | 900,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Lee Gary K. | Chief Scientific Officer | A | Option (right to buy) | 600000 | $0.00 | 600,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Thompson Rahsaan | Chief Legal Officer | A | Option (right to buy) | 245000 | $0.00 | 245,000.0000 | 0 | 9999.99% | 0.00% |
| Feb. 24, 2023 | Newton Charles W. | Chief Financial Officer | A | Option (right to buy) | 700000 | $0.00 | 700,000.0000 | 0 | 9999.99% | 0.00% |